Welcome
Welcome to the Pherecydes Pharma investor website,
Here you will find all the financial information dedicated to shareholders and investors.
Press release
05/23/2023 - 22:53
Availability of the Exemption document
04/17/2023 - 07:00
Pherecydes Pharma presented its Phagogram 1.5 at the ECCMID Congress
Subscribe to email alert
Ask us your questions
Contacts
Pherecydes Pharma
Thibaut du Fayet
CEO
Email : This email address is being protected from spambots. You need JavaScript enabled to view it.
NewCap
Investor Relations & Strategic Communication
Dusan Oresansky
+33 (0)1 44 71 94 92
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Medias Relations
Nicolas Merigeau
+33 (0)1 44 71 94 98
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.